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A remarkable feature ofmany skin diseases is that each affects distinct sites on
the body. The patterns are sufficiently characteristic and reproducible to be a
major clinical feature used to diagnose dermatologic diseases (1, 2). Unfortu-
nately, the cause for these differences is mostly unknown. One intriguing possi-
bility is that the location of lesions in autoimmune disease involving skin is
determined by regional variations in the expression of the target antigen(s).
To examine this possibility we have mapped the expression oftwo skin specific
antigens, the pemphigus vulgaris (PV) and bullous pemphigoid (BP) antigens, in
different regions of the body. These antigens are the targets of specific auto-
antibodies that cause two skin diseases, pemphigus vulgaris and bullous pemphi-
goid, in which the distribution of cutaneous lesions is markedly different. The
PV antigen is a 210 kD surface glycoprotein (3) synthesized by keratinocytes.
Antibodies to this antigen are the cause of pemphigus vulgaris (4), a disease
characterized by blisters that appear predominantly on the scalp, face, oral
mucosa, and upper torso (1, 2). The BP antigen is a 220-240 kD glycoprotein
(5) synthesized by epidermal basal cells (6, 7). Antibodies to this antigen are
believed to cause bullous pemphigoid (8), a disease characterized by bullae that
appear predominantly on the flexural surfaces ofthe body, and which spare the
face and scalp (1, 2). Antibodies to PV or BP antigens are present in the serum
and in the skin of most patients during the active phase oftherespective disease,
but are rare in normal individuals (8-10).
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Materials and Methods
BriefDefinitive Report
The expression of PV and BP antigens was assayed by indirect immunofluorescence,
as previously described (11), in 46 specimens of normal human skin. The skin specimens
were obtained by punch or excision biopsy from different areas on the body in different
individuals, immediately frozen in liquid nitrogen, cut in 4-'Urn sections on a cryostat, and
used within 1 wk. Each skin specimen was reacted with serial dilutions of three sera with
high titers (>640) of PV antibodies, three sera with high titers of BP antibodies, and
normal human serum. Antigen concentration was expressed as the highest dilution of
serum (end-point titer) that stainedthetarget antigen. This wasdetermined independently
by two investigators. The reading ofboth investigators was similar within one dilution.
This work wassupported in part by U.S. Public Health Service Research grant AM-27663, and by
the Rudolph Baer Foundation.
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FIGURE 1 .
￿
Indirect immunfluorescence photomicrograph of PV and BP antigen expression
in normal human skin . Specimens of skin obtained from different sites on the epiderm were
reacted with the same PV (a and b) or BP (c and d) serum . There is strong intercellular staining
of PV antigens in skin obtained from the neck (a) but not from the groin (b) ; and strong
basement zone staining of BP antigens in skin obtained from the groin (c) but not from the
face (d) . Photographs all taken at serum dilutions of 1 :160 .
Results and Discussion
The expression ofPV andBP antigens in 46 specimens ofnormal human skin,
measured by indirect immunofluorescence, was highly variable (Fig . 1, A-D) . It
ranged from undetectable levels (end-point titer of 0) to strong (end-point titer
?1,280) . Since a single serum of each specificity was used to assay all skin
specimens, the variations were not due to differences in antibody levels in the
serum . Nor were these differences due to day-to-day variation in the results of
indirect immunofluorescence assays, since in preliminary experiments we found
that there was only a twofold difference in end-point titer when replicate aliquots
of the same serum were tested repeatedly on the same or on different days
against replicate sections of the same specimen of skin . The most likely expla-
nation for the differences in result is that there were variations in antigen
expression in the different tissue specimens studied.
To examine whether the variation in antigen expression was random or
influenced by the site of origin of the skin, the results were reexamined after the
skin specimens had been grouped according to their location on the body . The
results obtained for PV antigen are presented in Fig 2. The expression of this
antigen in normal skin obtained from the same anatomic region was relatively
similar (on average, within one dilution), whereas it varied markedly (over seven
dilutions) in skin obtained from different sites . The causes for the usually smallSISON-FONACIER AND BYSTRYN
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FIGURE 2.
￿
Expression of PV antigen in skin from different sites in the body. Each point
represents the concentration of PV antigen in an individual skin specimen expressed as the
highest dilution of specific antibody reacting with antigen in the specimen.
variations in PV antigen expression in skin obtained from similar anatomic
regions probably include intrinsic limits on the reproducibilityofthe immunoflu-
orescence assays, which, as noted above, can lead to twofold dilution differences
in end-point titer, and possibly to small differences in antigen expression between
individuals. In addition, the large anatomic areas used to group the data may
not match exactly the actual pattern of antigen expression over the epiderm.
Consequently there may be some variation in antigen expression within each of
these arbitrarily selected regions. We believe the latter is the explanation for the
large variation in antigen expression in skin obtained from the chest and
abdomen, which includes areas that are commonly (upper chest) and rarely
(abdomen) involved in pemphigus.
The amount of PV antigen in different regions on the body was expressed as
the average end-point titer obtained when three sera with PV antibodies were
reacted with all skin specimens obtained from the same region. As shown in Fig.
3, PV antigen was strongly expressed in axilla, scalp, buccal mucosa, face, and
neck; areas commonly involved with lesions in pemphigus vulgaris (1, 2). 21 skin
specimens obtained from these sites were tested. All expressed PV antigen in
amounts yielding average end-point titers of 396-499. In contrast, expression
was low in the groin and lower back, areas rarely affected by pemphigus. Six
specimens were tested from these sites. No PV antigens could be detected in two
(33%). In the remainder, high concentrations (end-point titer <50) of PV
antibodies were required to detect the antigen, indicating that little was present.
Expression was intermediate in the other areas of the body studied, which are
occasionally affected by PV. These variations were not solely due to differences
in antigen concentration between individuals, since the expression of PV antigen
in similar regions in different individuals was relatively constant. Nor were they
due to PV antigen heterogeneity (12), since the variations persisted when the
same serum was used to assay all specimens (see Fig. 2).
To examine whether the cause for the regional variation in expression of PV
antigen is one that affected equally all antigenic properties of skin, or affected
this antigen selectively, we measured concurrently the expression of another
skin-specific antigen, the BP antigen, in all skin specimens. As shown in Fig. 3,2128
￿
SISON-FONACIER AND BYSTRYN
￿
BRIEF DEFINITIVE REPORT
REGIONAL VARIATION IN EXPRESSION OF
PV and BP ANTIGENS IN NORMAL HUMAN SKIN
Location:
Axillo
Scalp
Buccal
Mucoso
Face
Neck and
Shoulder
Leg
Upper Back
Chest and
Abdomen
Groin
Low to
Mid Back
PV Antigen
￿
BP Antigen
EXPRESSION OF ANTIGEN
( Mean End-Point Titer of Sera)
FIGURE 3.
￿
Mean expression of PV and BP antigen as a function of location on the body.
Each bar represents averageantigenexpression in allskin specimens obtained from stated site.
The average end-point titer is indicated within the bar. The error bar represents standard
error.
there was marked regional variations in the expression of BP antigen. There was
no correlation between the pattern of expression of PV and BP antigens. Scalp,
which strongly expressed PV antigen, expressed little BP antigen. Conversely,
expression of BP antigen was high in the groin and back, which expressed little
PV antigen. The independent variation in expression of the two antigens, when
measured concurrently in the same specimens of skin, indicate their expression
is under separate control. As with PV antigens, there was an overall correlation
between expression of BP antigen and location of lesions in this disease. Expres-
sion was high in areas commonly involved with lesions in bullous pemphigoid
(groin, axilla [1, 2]), very low in areas that are rarely involved (scalp, face, neck),
and variable in other areas (torso, extremities), which are less consistently
involved.
The results of these studies indicate that: (a) There are marked regional
variations in the antigenic properties of skin. (b) Different epidermal antigens
have different patterns of expression, indicating that their expression is under
separate genetic or environmental control. (c) There is a correlation between theSISON-FONACIER AND BYSTRYN
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expression of some epidermal antigens and the distribution of lesions in autoim-
mune skin disease involving these antigens. The results provide a previously
unavailable explanation for the distribution of skin lesions in pemphigus vulgaris
and bullous pemphigoid, and in general suggest that regional variations in the
antigenic properties of skin may be one of the factors that determines the location
of lesions in cutaneous diseases.
Summary
The possibility that the distribution of skin lesions in some cutaneous diseases
is due to variations in the antigenic properties ofskin was investigated by mapping
the expression of the skin-specific pemphigus vulgaris and bullous pemphigoid
antigens in different regions of the body. The expression of both antigens was
relatively stable within the same region, but varied between regions in a pattern
that was distinct for each antigen. For each antigen there was a correlation
between regions of high expression and location of skin lesions in autoimmune
diseases involving the antigen. The results indicate that there are marked regional
differences in the antigenic properties of skin and suggest this may influence the
distribution of cutaneous lesions in some skin diseases.
We thank Ms. Suzanne Tanner for her excellent technical assistance.
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